Details of the Drug Reposition

General Information of This Drug (ID: DMWX8UM)

Drug Name
Trehalose   DMWX8UM
Synonyms
trehalose; D-Trehalose; 99-20-7; alpha,alpha-trehalose; Mycose; Ergot sugar; alpha-D-Trehalose; D-(+)-Trehalose; alpha,alpha'-Trehalose; Trehaose; Treha; alpha-Trehalose; UNII-B8WCK70T7I; alpha-D-glucopyranosyl-alpha-D-glucopyranoside; D(+)-Trehalose; D-(+)-Trehalose, anhydrous; Natural trehalose; TREHALOSE, DIHYDRATE; alpha,alpha'-D-Trehalose; alpha-D-Glucopyranoside, alpha-D-glucopyranosyl; B8WCK70T7I; CHEBI:16551; alpha-D-glucopyranosyl alpha-D-glucopyranoside; Neotrehalose; Thealoz; NSC 2093; TRE; Trehalose, alpha,alpha'-; Trehalo
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Spinal cerebellar ataxia type 3 DISX5BQE 8A03 Phase 2 [1]
Muscular dystrophy DISJD6P7 8C70 Phase 2 [1]
Oculopharyngeal muscular dystrophy DISF4G07 9C82.1 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)